BTK and neoplasm: Among these compounds, derivative 16 (Figure 7) exhibited potent BTK inhibition (IC50 = 27 nM), high selectivity, antiproliferative effects in primary patient tumor cells, and strong apoptosis induction in Jeko-1 and Z138 cells.